Kudo To Go Ex-Dividend On June 27th, 2024 With 100 JPY Dividend Per Share
June 26th (Japan Standard Time) - $Kudo(1764.JP)$ is trading ex-dividend on June 27th, 2024.Shareholders of record on June 30th, 2024 will receive 100 JPY dividend per share. The ex-dividend date is J
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/30)
[Good Material] ――――――――――■Sanyo Homes [Tokyo Stock Exchange S] formulated a medium-term management plan. We aim for operating profit of 2.4 billion yen for the fiscal year ending 27/3 (results for the fiscal year ending 24/3 are 950 million yen). ■Petroleum Resources Development [TSE P] Participated in the “Freeport LNG Project” in Texas, USA. ■Kudo Construction [TSE S] will additionally acquire shares of Nikken Kikaku, which is an affiliated company applying the equity method, and make it a consolidated subsidiary. ■TOENEC
Kudo: (Numerical data correction) Partial correction of numerical data (XBRL) in the “Summary Financial Results for the 3rd Quarter of the Fiscal Year Ending June 2024 [Japanese GAAP] (Unconsolidated)”
Kudo: Confirmation letter
Kudo: Quarterly Report - 53rd Quarter (2024/01/01 to 2024/03/31)
Kudo Corp Sees Parent FY Net Y161.00M
Kudo Corp. also released the following forecasts: PARENT Year Ending Jun 2024 Revenue Y20.78 bln Operating Profit Y371.00 mln Pretax Profit Y25
Kudo: Summary of financial results for the 3rd quarter of the fiscal year ending June 2024 [Japanese GAAP] (unconsolidated)
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
Kudo Corp 1H Parent Net Y3.00M Vs Net Y62.00M
Kudo Corp. (1764.TO) Japan 1st Half Ended December 31 PARENT 2023 2022 Revenue Y9.72 bln Y9.56 bln Operating Profit Y54.00 mln Y171.00 mln
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform Into CDMO Kudo Biotechnology's MRNA Manufacturing Workflow
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -STONY BROOK, NY and NEEDH
Kudo Corp 1Q Parent Net Y20.00M Vs Net Y26.00M
Kudo Corp. (1764.TO) Japan 1st Quarter Ended September 30 PARENT 2023 2022 Revenue Y4.64 bln Y4.58 bln Operating Profit Y57.00 mln Y79.00 ml
PackGene Biotech and Kudo Biotechnology Partner to Offer Customized MRNA Manufacturing Services
Collaboration provides end-to-end coverage of mRNA drug and vaccine development and manufacturing workflow HOUSTON and NEEDHAM, Mass., Sept. 19, 2023 /PRNewswire/ -- PackGene Biotech (PackGene) and Kudo Biotechnology
Kudo Corp FY Parent Net Y135.00M Vs Net Y121.00M
Kudo Corp. (1764.TO) Japan Year Ended June 30 PARENT 2023 2022 Revenue Y19.58 bln Y17.01 bln Operating Profit Y333.00 mln Y240.00 mln Pret
Kudo Corp 1H Parent Net Y62.00M Vs Loss Y8.00M
Kudo Corp. (1764.TO) Japan 1st Half Ended December 31 PARENT 2022 2021 Revenue Y9.56 bln Y7.55 bln Operating Profit Y171.00 mln Y
Kudo Corp Sees Parent FY Net Y110.00M
Kudo Corp. also released the following forecasts: PARENT Year Ending Jun 2023 Revenue Y20.48 bln Operating Profit Y275.00 mln Pretax Profit Y17
No Data